John Rebecca, Williams Gwyn, Morgan Tim, George Michael R, Reynolds Rhianon, Acton Jennifer H
Wales General Ophthalmic Services, NHS Wales, Shared Services Partnership, Cardiff, UK.
Singleton Hospital, Swansea, UK.
Ophthalmic Physiol Opt. 2025 Jan;45(1):308-314. doi: 10.1111/opo.13413. Epub 2024 Nov 1.
The certificate of vision impairment has an important role in enabling access to support for people with vision impairment (VI) and the provision of epidemiological data regarding sight loss. However, the rates of certification may not accurately reflect the number of people living with certifiable VI.
Observational data from a national primary care low vision rehabilitation service between 1 April 2021 and 31 March 2022 were analysed. Descriptive statistics were used to describe the certification status of patients with certifiable VI. For patients with age-related macular degeneration (AMD) and best-corrected visual acuity of 6/60 or worse, logistic regression was undertaken to assess the effects of patient characteristics on certification status.
For patients with AMD and certifiable levels of visual acuity, 41.00% (n = 426) were not certified. The reported certification was 60.09% (n = 256) and 58.24% (n = 357) for neovascular AMD and atrophic AMD, respectively. Existing patients of the service were 3.87 times more likely to be certified than new patients (OR 3.87, 95% CI 2.7-5.4). Increasing age (OR 1.02, 95% CI 1.004-1.038) and decreasing visual acuity (OR 0.62, 95% CI 0.50-0.78) were associated with an increased likelihood of certification.
A significant number of patients live with certifiable vision impairment but do not access certification. Policy changes in Wales now enable patients with bilateral atrophic AMD to access certification within the primary care setting. Given the unmet need, consideration should be given to primary care certification in the rest of the UK, and in Wales, the potential to expand the scope of conditions.
视力障碍证书在帮助视力障碍者获得支持以及提供视力丧失的流行病学数据方面发挥着重要作用。然而,认证率可能无法准确反映可认证视力障碍者的实际人数。
对2021年4月1日至2022年3月31日期间全国基层医疗低视力康复服务的观察数据进行了分析。使用描述性统计来描述可认证视力障碍患者的认证状况。对于年龄相关性黄斑变性(AMD)且最佳矫正视力为6/60或更差的患者,进行逻辑回归以评估患者特征对认证状况的影响。
对于患有AMD且视力可认证的患者,41.00%(n = 426)未获得认证。新生血管性AMD和萎缩性AMD的报告认证率分别为60.09%(n = 256)和58.24%(n = 357)。该服务的现有患者获得认证的可能性是新患者的3.87倍(OR 3.87,95% CI 2.7 - 5.4)。年龄增加(OR 1.02,95% CI 1.004 - 1.038)和视力下降(OROR 0.62,95% CI 0.50 - 0.78)与认证可能性增加相关。
大量患者患有可认证的视力障碍但未获得认证。威尔士的政策变化现在使双侧萎缩性AMD患者能够在基层医疗环境中获得认证。鉴于需求未得到满足,应考虑在英国其他地区进行基层医疗认证,以及在威尔士扩大认证条件范围的可能性。